@oncologyventure.com
Allarity Therapeutics is a clinical-stage precision medicine company actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
Allarity Therapeutics is a precision medicine company that specializes in personalized cancer care. With a focus on patients with difficult-to-treat cancers, they are actively advancing a pipeline of in-licensed oncology therapeutics. Their clinical program includes five anti-cancer assets that are in mid- to late-stage clinical development.
The company utilizes their proprietary Drug Response Predictor (DRP®) technology to refine patient selection and improve clinical outcomes. The DRP® technology has been extensively validated and is known for its high degree of accuracy in matching the right patient to the right drug. By identifying patients who will respond and those who will not, Allarity's companion diagnostics have the potential to transform cancer therapeutic development by increasing clinical success rates and improving patient outcomes.
Allarity Therapeutics is publicly traded on NASDAQ and is committed to enhancing patient outcomes through personalized cancer care
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online